In-stent neoatherosclerosis: a final common pathway of late stent failure.

[1]  Seung‐Jung Park,et al.  Optical Coherence Tomographic Analysis of In-Stent Neoatherosclerosis After Drug–Eluting Stent Implantation , 2011, Circulation.

[2]  Mark E Brezinski,et al.  Current capabilities and challenges for optical coherence tomography as a high-impact cardiovascular imaging modality. , 2011, Circulation.

[3]  J. Hamburger,et al.  In‐stent restenotic lesions can rupture—A case against plaque sealing , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[4]  Masataka Nakano,et al.  The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. , 2011, Journal of the American College of Cardiology.

[5]  R. Virmani,et al.  Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents. , 2011, Journal of the American College of Cardiology.

[6]  Seung‐Jung Park,et al.  Tissue characterization of in-stent neointima using intravascular ultrasound radiofrequency data analysis. , 2010, The American journal of cardiology.

[7]  Y. Hayashi,et al.  Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry). , 2010, The American journal of cardiology.

[8]  Seung‐Jung Park,et al.  Long-term vascular changes after drug-eluting stent implantation assessed by serial volumetric intravascular ultrasound analysis. , 2010, The American journal of cardiology.

[9]  Seung‐Jung Park,et al.  Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation. , 2010, Journal of the American College of Cardiology.

[10]  Renu Virmani,et al.  Pathological findings at bifurcation lesions: the impact of flow distribution on atherosclerosis and arterial healing after stent implantation. , 2010, Journal of the American College of Cardiology.

[11]  Yoshihiko Seino,et al.  Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents extended late-phase observation by intracoronary optical coherence tomography. , 2009, Journal of the American College of Cardiology.

[12]  A. Maseri,et al.  Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stents. , 2009, The American journal of cardiology.

[13]  M. Terashima,et al.  Detection of atherosclerotic progression with rupture of degenerated in-stent intima five years after bare-metal stent implantation using optical coherence tomography. , 2009, The Journal of invasive cardiology.

[14]  Gijs van Soest,et al.  Optical coherence tomography patterns of stent restenosis. , 2009, American heart journal.

[15]  T. Gori,et al.  Atheromatous degeneration of the neointima in a bare metal stent: intravascular ultrasound evidence. , 2009, Journal of cardiovascular medicine.

[16]  Renu Virmani,et al.  One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis. , 2009, JACC. Cardiovascular imaging.

[17]  K. Kodama,et al.  Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study. , 2009, JACC. Cardiovascular imaging.

[18]  M. Takano,et al.  Extended Follow-Up by Serial Angioscopic Observation for Bare-Metal Stents in Native Coronary Arteries: From Healing Response to Atherosclerotic Transformation of Neointima , 2009, Circulation. Cardiovascular interventions.

[19]  A. Colombo,et al.  TAXUS VI final 5-year results: a multicentre, randomised trial comparing polymer-based moderate-release paclitaxel-eluting stent with a bare metal stent for treatment of long, complex coronary artery lesions. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[20]  V. Džavík,et al.  A calcified neointima--"stent" within a stent. , 2009, The Journal of invasive cardiology.

[21]  Aloke V. Finn,et al.  Delayed Arterial Healing and Increased Late Stent Thrombosis at Culprit Sites After Drug-Eluting Stent Placement for Acute Myocardial Infarction Patients: An Autopsy Study , 2008, Circulation.

[22]  Michael Joner,et al.  Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[23]  N. Weissman,et al.  Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation: late "catch-up" phenomenon from ASPECT Study. , 2006, Journal of the American College of Cardiology.

[24]  K. Ono,et al.  Histopathological findings of new in‐stent lesions developed beyond five years , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[25]  Michael Joner,et al.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. , 2006, Journal of the American College of Cardiology.

[26]  P. Tsao,et al.  Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model. , 2004, Cardiovascular research.

[27]  R. Virmani,et al.  Extracellular Matrix Changes in Stented Human Coronary Arteries , 2004, Circulation.

[28]  Michio Nakanishi,et al.  Pathological analyses of long-term intracoronary Palmaz-Schatz stenting; Is its efficacy permanent? , 2004, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[29]  Antonio Colombo,et al.  Mechanism of Late In-Stent Restenosis After Implantation of a Paclitaxel Derivate–Eluting Polymer Stent System in Humans , 2002, Circulation.

[30]  E. Tuzcu,et al.  Coronary Plaque Classification With Intravascular Ultrasound Radiofrequency Data Analysis , 2002, Circulation.

[31]  M. Nobuyoshi,et al.  Long-Term Clinical and Angiographic Follow-Up After Coronary Stent Placement in Native Coronary Arteries , 2002, Circulation.

[32]  C. Di Mario,et al.  First Clinical Experience With a Paclitaxel Derivate–Eluting Polymer Stent System Implantation for In-Stent Restenosis: Immediate and Long-Term Clinical and Angiographic Outcome , 2002, Circulation.

[33]  R. Virmani,et al.  Pathological Analysis of Local Delivery of Paclitaxel Via a Polymer-Coated Stent , 2001, Circulation.

[34]  Renu Virmani,et al.  Healed Plaque Ruptures and Sudden Coronary Death: Evidence That Subclinical Rupture Has a Role in Plaque Progression , 2001, Circulation.

[35]  A. Becker,et al.  Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses. , 1998, Circulation.

[36]  H Yokoi,et al.  Three-year follow-up after implantation of metallic coronary-artery stents. , 1996, The New England journal of medicine.

[37]  E. Arbustini,et al.  Comparison of coronary lesions obtained by directional coronary atherectomy in unstable angina, stable angina, and restenosis after either atherectomy or angioplasty. , 1995, The American journal of cardiology.

[38]  W Rutsch,et al.  A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. , 1994, The New England journal of medicine.

[39]  K. Kodama,et al.  Neointimal coverage of stents in human coronary arteries observed by angioscopy. , 1994, Journal of the American College of Cardiology.

[40]  M. Aschermann.  [Restenosis after percutaneous transluminal coronary angioplasty]. , 1990, Casopis lekaru ceskych.

[41]  R A Schatz,et al.  Balloon-expandable intracoronary stents in the adult dog. , 1987, Circulation.

[42]  A. Ionescu,et al.  Bare metal stent restenosis is not a benign clinical entity. , 2006, American heart journal.